Final clinical, pharmacokinetic and pharmacodynamic results of the phase I study of the novel poly(ADP-ribose)polymerase (PARP) inhibitor, AG014699, in combination with temozolomide

  1. Lookup NU author(s)
  2. Professor Ruth Plummer
  3. Professor Alan Boddy
  4. Professor Nicola Curtin
  5. Professor Herbie Newell
  6. Lynsey Robson
  7. Professor Alan Calvert
Author(s)Plummer ER, Middleton M, Wilson R, Evans J, Jones C, Olson A, Boddy AV, Curtin NJ, Kaufman R, Harris A, Johnston P, Newell DR, Robson L, Dewji R, Calvert AH
Publication type Conference Proceedings (inc. Abstract)
Conference NameAACR/NCI/EORTC International Conference on Molecular Targets and Cancer Therapeutics
Conference LocationPhiladelphia, PA
Year of Conference2005
Source Publication Date14-18 November 2005
Volume11, issue 24 (Part 2 Suppl. S)
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
PublisherClinical Cancer Research: American Association for Cancer Research
Actions    Link to this publication
Library holdingsSearch Newcastle University Library for this item